E-EDV-D682

N/A

Report date: 2026/02/06 20:01:23

Base Information

Drug NameE-EDV-D682
Drug Alias NameEGFR VEDVsPNUEGFR VEDVsPNU+EDVs40 merEGFR-VEDVsPNUD682-carrying EDVEGFR-EDV-PNU-15982 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PNU-159682 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEngeneic Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEngeneic LtdEngeneic Pty Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A